Cho Kwang Pain (004910) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.21x

Cho Kwang Pain (004910) has a Cash Flow Reinvestment Rate of 1.21x as of September 2025, reinvesting ₩4.31 Billion (capex ₩2.30 Billion plus investments ₩2.01 Billion) from operating cash flow of ₩3.56 Billion. See 004910 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.21x
(Capex + Investments) / Operating CF

Total Reinvested

₩4.31 Billion
Capex + Investments

Operating Cash Flow

₩3.56 Billion
KRW

Capital Expenditures

₩2.30 Billion
KRW

Cho Kwang Pain Cash Flow Reinvestment Rate (2012–2024)

Historical reinvestment intensity for Cho Kwang Pain across 10 annual periods. For the full cash flow conversion analysis, see 004910 cash flow conversion.

Annual Cash Flow Reinvestment Rate for Cho Kwang Pain (2012–2024)

Year-by-year capital reinvestment analysis for Cho Kwang Pain. See Cho Kwang Pain leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.80x ₩15.88 Billion ₩19.75 Billion ₩13.30 Billion ▼ -52.9%
2023 1.71x ₩25.24 Billion ₩14.78 Billion ₩12.87 Billion ▲ +116.5%
2020 0.79x ₩11.31 Billion ₩14.33 Billion ₩11.19 Billion ▼ -49.1%
2019 1.55x ₩19.09 Billion ₩12.31 Billion ₩16.39 Billion ▼ -22.3%
2017 1.99x ₩26.78 Billion ₩13.43 Billion ₩19.32 Billion ▲ +186.6%
2016 0.70x ₩12.63 Billion ₩18.15 Billion ₩6.06 Billion ▲ +340.7%
2015 0.16x ₩3.35 Billion ₩21.20 Billion ₩2.95 Billion ▼ -81.6%
2014 0.86x ₩16.73 Billion ₩19.45 Billion ₩15.20 Billion ▲ +47.8%
2013 0.58x ₩5.73 Billion ₩9.85 Billion ₩3.50 Billion ▼ -8.2%
2012 0.63x ₩4.78 Billion ₩7.55 Billion ₩4.78 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow